经皮冠状动脉介入治疗术后老年患者多重用药管理方案的构建

doi:10.3761/j.issn.0254-1769.2023.12.010

摘要/Abstract

摘要：

目的构建经皮冠状动脉介入治疗术后老年患者多重用药管理方案，以保证患者用药安全。方法 2022年1月—7月，基于循证方法，系统检索国内外文献，以4R危机管理理论为指导，经研究小组讨论，制订经皮冠状动脉介入治疗术后老年患者多重用药管理方案初稿，并通过德尔菲专家函询形成方案终稿。结果共15名专家完成2轮函询，问卷有效回收率均为100%；专家权威系数为0.90；第2轮专家意见重要性及可行性肯德尔和谐系数分别为0.216、0.289。最终形成的经皮冠状动脉介入治疗术后老年患者多重用药管理方案包括风险缩减、风险预备、危机应对和监控反馈4项一级指标、7项二级指标、23项三级指标。结论该研究构建的经皮冠状动脉介入治疗术后老年患者多重用药管理方案科学全面，可为患者的多重用药管理提供理论依据和实践方向。

关键词: 老年人, 经皮冠状动脉介入治疗, 多重用药, 用药管理, 危机管理理论, 德尔菲技术, 护理

Abstract:

Objective To construct a program for elderly patients with polypharmacy after percutaneous coronary intervention，and to ensure the safety of patients’ polypharmacy throughout the process. Methods Based on evidence-based methods to retrieve domestic and foreign literature，and guided by the 4R crisis management theory，the first draft of the medication management program was formulated by the research group，and the final program was revised and established according to the experts’ opinions by Delphi method from January to July 2022. Results 15 experts participated in 2 rounds of consultations，and the effective recovery rate of questionnaire was 100%. The expert authority scores of 2 rounds were 0.90，and the importance and operability of the second round of expert opinions Kendall harmony were 0.216 and 0.289. The final program contained 4 primary indicators，7 secondary indicators and 23 tertiary indicators. Conclusion The constructed medication management program for elderly patients with polypharmacy after percutaneous coronary intervention is scientific and comprehensive，which can provide a theoretical basis and practical direction for the management of patients.

Key words: Aged, Percutaneous Coronary Intervention, Polypharmacy, Medication Therapy Management, 4R-Model Crisis Management Theory, Delphi Technique, Nursing Care

程婷, 涂惠, 熊晓云, 郭婷, 张卫芳, 彭莹. 经皮冠状动脉介入治疗术后老年患者多重用药管理方案的构建[J]. 中华护理杂志, 2023, 58(12): 1476-1482.

CHENG Ting, TU Hui, XIONG Xiaoyun, GUO Ting, ZHANG Weifang, PENG Ying. Construction of a medication management program of elderly patients with polypharmacy after percutaneous coronary intervention[J]. Chinese Journal of Nursing, 2023, 58(12): 1476-1482.

图/表 1

参考文献 25

[1]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6):553-578.
	The Writing Committee of the Report on Cardiovascular Health,China DI. Report on cardiovascular health and diseases in China 2021:an updated summary[J]. Chin Circ J, 2022, 37(6):553-578.
[2]	高立建, 袁晋青. 经皮冠状动脉介入治疗技术和器械进展[J]. 中华心血管病杂志, 2022, 50(2):112-116. PMID
	Gao LJ, Yuan JQ. Techniques and instruments advances in percutaneous coronary intervention[J]. Chin J Cardiol, 2022, 50(2):112-116. DOI PMID
[3]	王雅, 程继芳, 刘重斌, 等. 经皮冠状动脉介入治疗后患者早期再入院的研究进展[J]. 中华护理杂志, 2020, 55(10):1598-1600. DOI URL
	Wang Y, Cheng JF, Liu CB, et al. Research progress on early readmission of patients after percutaneous coronary intervention[J]. Chin J Nurs, 2020, 55(10):1598-1600. DOI URL
[4]	周树军, 王云梅, 王振娟, 等. 出院后药学干预对基层医院PCI术后冠心病患者用药依从性及其预后的影响[J]. 中国药房, 2017, 28(8):1126-1129.
	Zhou SJ, Wang YM, Wang ZJ, et al. Effects of pharmaceutical intervention after discharge on medication compliance and the prognosis of coronary artery disease patients after PCI in primary hospital[J]. China Pharm, 2017, 28(8):1126-1129.
[5]	严研, 公威, 王晓, 等. 多病共患的老年急性冠状动脉综合征患者抗栓治疗情况及预后分析[J]. 中华心血管病杂志, 2022, 50(5):443-449. PMID
	Yan Y, Gong W, Wang X, et al. Multimorbidity in elderly patients with acute coronary syndrome:insights from BleeMACS registry[J]. Chin J Cardiol, 2022, 50(5):443-449. DOI PMID
[6]	World Health Organization. Medication safety in polypharmacy:technical report[EB/OL].(2019-06-20)[2022-10-10]. .
[7]	曹小帆. 老年ACS患者多重用药情况及不同代谢特点的他汀不良反应分析[D]. 沈阳: 中国医科大学, 2018.
	Cao XF. The analysis of polypharmacy status and adverse reactions of statins with different metabolic characteristics in elderly ACS patients[D]. Shenyang: China Medical University, 2018.
[8]	国家重点研发项目(2018YFC2002400)课题组. 高龄老年共病患者多重用药安全性管理专家共识[J]. 中华保健医学杂志, 2021, 23(5):548-554.
	National Key Research and Development Project(2018YFC2002400) Research Group. Expert consensus on safety management of multiple drugs for elderly comorbid patients[J]. Chin J Health Care Med, 2021, 23(5):548-554.
[9]	彭一航, 谢莉玲, 梁燕, 等. 智能药物管理系统在养老机构老年人中的应用[J]. 中华护理杂志, 2021, 56(5):680-686. DOI URL
	Peng YH, Xie LL, Liang Y, et al. Efficacy of intelligent medi-cation management system in elderly people in care institu-tions[J]. Chin J Nurs, 2021, 56(5):680-686.
[10]	Mcarthur A, Klugarová J, Yan H, et al. JBI manual for evidence synthesis. Chapter 4:systematic reviews of text and opinion[M]. Adelaide: the Joanna Briggs Institute, 2020.
[11]	Moola S, Munn Z, Tufanaru C, et al. JBI manual for evidence synthesis.Chapter 7:systematic reviews of etiology and risk[M]. Adelaide: the Joanna Briggs Institute, 2020.
[12]	NICE. Medicines optimisation:the safe and effective use of medicines to enable the best possible outcomes[EB/OL]. ( 2015-03-04)[2022-04-01]. http://www.nice.Org.uk/guidance/ng5.
[13]	NICE. Managing medicines for adults receiving social care in the community[EB/OL].(2017-03-30) [2022-04-01]. http://www.nice.org.uk/guidance/ng67.
[14]	Barnason S, White-Williams C, Rossi LP, et al. Evidence for therapeutic patient education interventions to promote cardiovascular patient self-management:a scientific statement for healthcare professionals from the American Heart Association[J]. Circ Cardiovasc Qual Outcomes, 2017, 10(6):e000025.
[15]	中国老年保健医学研究会老龄健康服务与标准化分会, 《中国老年保健医学》杂志编辑委员会. 居家(养护)老年人共病综合评估和防控专家共识[J]. 中国老年保健医学, 2018, 16(3):28-31.
	Geriatric Health Service and Standardization Association, China Geriatric Medical Research Society, Editorial Board of Chinese Journal of Geriatric Care. China Geriatric Medical Research Society,Editorial Board of Chinese Journal of Geriatric Care.Expert consensus on comprehensive evaluation and prevention and control of comorbidity among elderly people at home(care)[J]. Chin J Geriatr Care, 2018, 16(3):28-31.
[16]	国家重点研发计划项目(2020YFC2006100、2018YFC2002400)课题组, 中国老年医学学会医养结合促进委员会. 医养结合机构老年共病患者安全用药专家共识[J]. 中华保健医学杂志, 2021, 23(6):561-568.
	Research Group on National Key Research and Development Program(2020YFC2006100、2018YFC2002400), Committee for the Promotion of Integration of Medical and Nursing Care of Chinese Geriatrics Society. Expert consensus on medication safety for older adults with comorbidities in institutions integrating medical and elderly care services[J]. Chin J Health Care Med, 2021, 23(6):561-568.
[17]	中华医学会, 中华医学会临床药学分会, 中华医学会杂志社, 等. 冠心病心脏康复基层合理用药指南[J]. 中华全科医师杂志, 2021, 20(3):311-320.
	Chinese Medical Association, Chinese Society of Clinical Pharmacy, Chinese Medical Journals Publishing House, et al. Guideline for rational medication of cardiac rehabilitation of coronary artery disease in primary care[J]. Chin J Gen Pract, 2021, 20(3):311-320.
[18]	Muth C, Blom JW, Smith SM, et al. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy:a systematic guideline review and expert consensus[J]. J Intern Med, 2019, 285(3):272-288. DOI PMID
[19]	Liau SJ, Lalic S, Sluggett JK, et al. Medication management in frail older people:consensus principles for clinical practice,research,and education[J]. J Am Med Dir Assoc, 2021, 22(1):43-49. DOI URL
[20]	Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people[J]. Cochrane Database Syst Rev, 2018, 9(9):CD008165.
[21]	Cross AJ, Elliott RA, Petrie K, et al. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications[J]. Cochrane Database Syst Rev, 2020, 5(5):CD012419.
[22]	Henriksson R, Huber D, Mooe T. Nurse-led,telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months:the randomized controlled NAILED-ACS trial[J]. Sci Rep, 2021, 11(1):17693. DOI PMID
[23]	罗伯特·希斯. 危机管理[M]. 王成,宋炳辉,金瑛,译. 北京: 中信出版社, 2001:1.
	Robert Health. Crisis management[M]. Wang C,Song BH,Jin Y,Trans. Beijing: China CITIC Press Group, 2001:1.
[24]	晋聪聪, 商临萍. 4R危机管理理论在新型冠状病毒肺炎防控中的应用研究[J]. 中华护理杂志, 2020, 55(增刊1):243-245.
	Jin CC, Shang LP. Research on application of 4R crisis management theory in prevention and control of coronavirus disease 2019[J]. Chin J Nurs, 2020, 55(S1):243-245.
[25]	卢学萍, 黄霞, 贾培培, 等. 经皮冠状动脉介入治疗患者延续护理质量评价指标体系的构建[J]. 中华护理杂志, 2021, 56(1):73-79. DOI URL
	Lu XP, Huang X, Jia PP, et al. Construction of an evaluation index system for hospital-community linkage continued nursing quality after percutaneous coronary intervention[J]. Chin J Nurs, 2021, 56(1):73-79. DOI URL